Leptin receptor expression in neoplastic and normal ovarian and endometrial tissue

European Journal of Gynaecological Oncology

Volumn 32, Issue 1, 2011, Pages 84-86

  Mantzos, F ^a   Vanakara, P ^b   Samara, S ^b   Wosniak, G ^b   Kollia, P ^c   Messinis, I ^b   Hatzitheofilou, C ^b  

^a Patissionand Kefalinias Athens   (Greece)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cancer; Endometrium; Leptin; Ovary; Receptor

Indexed keywords

LEPTIN RA RECEPTOR; LEPTIN RB RECEPTOR; LEPTIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OBESITY; OVARY; OVARY ADENOCARCINOMA; OVARY CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS; UTERUS MYOMA;

ADULT; AGED; BODY MASS INDEX; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; RECEPTORS, LEPTIN;

EID: 79952343555     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tanaka T., Umesaki N.: "Leptin regulates the proliferation and apoptosis of human endometrial epithelial cells". Int. J. Mol. Med., 2008, 22, 683.
2. Calabro P., Yeh ET. : "Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ". Subcell. Biochem., 2007, 42, 63.
3. Petridou E., Papadiamantis Y., Markopoulos C., Spanos E., Dessypris N., Trichopoulos D.: "Leptin and insulin growth factor I in relation to breast cancer (Greece)". Cancer. Causes Control., 2000, 11, 383.
4. Koda M., Sulkowska M., Wincewicz A., Kanczuga-Koda L., Musiatowicz B., Szymanska M., Sulkowski S.: "Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer". Ann. N. Y. Acad. Sci., 2007, 1095, 90.
5. Sharma D., Saxena N., Vertino P., Anania F. : "Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways". Endocrine-Related Cancer, 2006, 13, 629.
6. Petridou E., Belechri M., Dessypris N., Koukoulomatis P., Diakomanolis E., Spanos E., Trichopoulos D.: "Leptin and body mass index in relation to endometrial cancer risk". Ann. Nutr. Metab., 2002, 46, 147.
7. Anderson A.S., Caswell S. : "Obesity management-an opportunity for cancer prevention". Surgeon., 2009, 7, 282.
8. Purdie D.M., Bain C.J., Webb P.M., Whiteman D.C., Pirozzo S., Green A.C.: "Body size and ovarian cancer: case-control study and systematic review (Australia)". Cancer Causes Control., 2001, 12, 855.
9. Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M.: "Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies". Lancet., 2008, 371, 569.
10. Yuan S.S., Tsai K.B., Chung Y.F., Chan T.F., Yeh Y.T., Tsai L.Y. et al.: "Aberrant expression and possible involvement of the Ob receptor in endometrial cancer". Gynecol. Oncol., 2004, 92, 769.
11. Kitawaki J., Koshiba H., Ishihara H., Kusuki I., Tsukamoto K., Honjo H.: "Expression of leptin receptor in human endometrium and fluctuation during the menstrual cycle". J. Clin. Endocrinol. Metab., 2000, 85, 1946.
12. Carino C., Olawaiye A.B., Cherfils S., Serikawa T., Lynch M.P., Rueda B.R., Gonzalez R.R.: "Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells". Int. J. Cancer., 2008, 123, 2782.